These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1570 related items for PubMed ID: 21877763

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Botulinum toxin A (Botox Cosmetic): a review of its use in the treatment of glabellar frown lines.
    Frampton JE, Easthope SE.
    Am J Clin Dermatol; 2003; 4(10):709-25. PubMed ID: 14507232
    [Abstract] [Full Text] [Related]

  • 4. Current and future botulinum neurotoxin type A preparations in aesthetics: a literature review.
    Sattler G.
    J Drugs Dermatol; 2010 Sep; 9(9):1065-71. PubMed ID: 20865836
    [Abstract] [Full Text] [Related]

  • 5. Dosing, efficacy and safety plus the use of computerized photography for botulinum toxins type A for upper facial lines.
    Lowe NJ, Shah A, Lowe PL, Patnaik R.
    J Cosmet Laser Ther; 2010 Apr; 12(2):106-11. PubMed ID: 20151785
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Botulinum toxin-B and the management of hyperhidrosis.
    Baumann LS, Halem ML.
    Clin Dermatol; 2004 Apr; 22(1):60-5. PubMed ID: 15158547
    [Abstract] [Full Text] [Related]

  • 11. Multicenter, randomized, phase III study of a single dose of incobotulinumtoxinA, free from complexing proteins, in the treatment of glabellar frown lines.
    Carruthers A, Carruthers J, Coleman WP, Donofrio L, Flynn T, Gold M, Heinz M, Harrington L, Jones D, McDaniel D, Rohrer T, Schlöbe A, Solish N, Weiss RA.
    Dermatol Surg; 2013 Apr; 39(4):551-8. PubMed ID: 23379292
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines.
    Carruthers JA, Lowe NJ, Menter MA, Gibson J, Nordquist M, Mordaunt J, Walker P, Eadie N, BOTOX Glabellar Lines I Study Group.
    J Am Acad Dermatol; 2002 Jun; 46(6):840-9. PubMed ID: 12063480
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Botulinum toxin type A for the treatment of glabellar rhytides.
    Carruthers A, Carruthers J.
    Dermatol Clin; 2004 Apr; 22(2):137-44. PubMed ID: 15222573
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Overview of DaxibotulinumtoxinA for Injection: A Novel Formulation of Botulinum Toxin Type A.
    Solish N, Carruthers J, Kaufman J, Rubio RG, Gross TM, Gallagher CJ.
    Drugs; 2021 Dec; 81(18):2091-2101. PubMed ID: 34787840
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 79.